Stock Research: Cerus

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Cerus

NasdaqGM:CERS US1570851014
23
  • Value
    37
  • Growth
    46
  • Safety
    Safety
    45
  • Combined
    32
  • Sentiment
    30
  • 360° View
    360° View
    23
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Cerus Corporation is a biomedical products company focused on enhancing blood safety. It operates in the biomedical industry, specializing in the INTERCEPT Blood System. Cerus Corporation operates globally. In the last fiscal year, the company had a market cap of $260 million, profits of $121 million, and revenue of $201 million, with 281 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 23 (better than 23% compared with alternatives), overall professional sentiment and financial characteristics for the stock Cerus are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with all four indicators below average for Cerus. The consolidated Value Rank has a low rank of 45 which means that the share price of Cerus is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 55% of alternative stocks in the same industry. The consolidated Growth Rank also has a low rank of 46, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is lower than for 46% of competitors in the same industry. The consolidated Safety Rank has a riskier rank of 37, which means that the company has a riskier financing structure than 63% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a low rank of 30, which means that professional investors are more pessimistic about the stock than for 70% of alternative investment opportunities. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
45 27 23 31
Growth
46 89 65 53
Safety
Safety
37 31 27 22
Sentiment
30 33 14 82
360° View
360° View
23 39 4 50
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
29 37 26 93
Opinions Change
50 65 50 50
Pro Holdings
n/a 8 6 6
Market Pulse
75 66 39 90
Sentiment
30 33 14 82
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
45 27 23 31
Growth
46 89 65 53
Safety Safety
37 31 27 22
Combined
32 44 18 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
22 22 22 22
Price vs. Earnings (P/E)
91 69 69 48
Price vs. Book (P/B)
15 13 11 14
Dividend Yield
1 1 1 1
Value
45 27 23 31
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
59 80 77 39
Profit Growth
30 85 61 52
Capital Growth
46 65 37 57
Stock Returns
40 49 29 57
Growth
46 89 65 53
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
18 23 26 49
Refinancing
60 53 47 35
Liquidity
41 37 42 23
Safety Safety
37 31 27 22

Similar Stocks

Discover high‑ranked alternatives to Cerus and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Cigna

NYSE:CI
Country: USA
Industry: Health Care Services
Size: XX-Large
Full Stock Analysis

TEGNA

NYSE:TGNA
Country: USA
Industry: Broadcasting
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.